BIOL3060 Long QT Syndrome and the hERG channel

11:48   hERG: the Cardiac Safety Risk that can Derail a Drug Programme 4:24   Yaz Gelince İrençberler Herg Eder Şu Söğütte Bir Kuş Var YURTTAN SESLER KOROSU 4:50   hERG channel inhibition & cardiotoxicity 5:44   Exploring hERG gating through MD simulations and network analysis 4:12   Herg eden Oğlan | Türkü Candır | Anatolia 4:11   Testing hERG Alone Isn't Enough - CiPA, the New Cardiac Drug Safety Paradigm 5:14   Creative Bioarray hERG Safety Assay 0:26   hERG Channel in Action 3:39   reducing hERG activity of a lead compound 3:14   Molecular recognition of Herg blockers and influence of their molecular electrostatics 6:32   Automatisiertes Patch-Clamp-Assay an HEK hERG Zellen mit dem CytoPatch™ 2 0:33   Enhancing Drug Safety with HERG Testing: Strategies for Ion Channel Screening